• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aneurysm (1708); Stroke/CVA (1770); Hematoma (1884); Hemorrhage/Bleeding (1888); Transient Ischemic Attack (2109)
Event Date 03/01/1999
Event Type  Injury  
Manufacturer Narrative
(b)(4).Age at event: average age.Pt gender: gender majority.Date of event: estimate from content of article literature: mendiz, o.A., et al.(2016)."transradial versus transfemoral carotid artery stenting: a 16-year single-center experien ce." journal of interventional cardiology 29(6): 588-593 doi: 10.1111/joic.12342.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A study was performed to investigate transradial versus transfemoral carotid artery stenting.Study ranged from march 1999 to march 2015 and included 775 patients.In tr group average patient age was 71 years and 79.2% were male.In tf group average patient age was 69.7 years and 70.9% were male.The following medtronic devices were used in the study; spider, protege, cristallo ideale, moma <(>&<)> percusurge.Stent deployment technique did not differ from the one used with tf-cas.Distal protection was used in all tr cases and in most tf (some cases were done with proximal protection).Patients were examined post-procedure during their hospital stay.Stroke was reported for 20 patients.Approx 1 of them occurred in the contralateral territory in the context of new-onset atrial fibrillation.This stroke was judged to be cardioembolic in nature.Approx 11 cases of tia were reported.Four patients had major bleeding, 1 of them requiring vascular surgery due to retroperitoneal aneurysm.Two other patients had superficial femoral aneurysm, 1 of them requiring thrombin injection.Approx 1 patient had a forearm hematoma that was treated medically.Approx 7 patient deaths occurred during post-operative hospital stay, all in the context of combined coronary artery bypass grafting and percutaneous carotid intervention mainly related to complications of cardiac surgery.Approx 3 further patient deaths were reported during 30 day follow-up.The investigator assessed that none of reported events in this publication were attributed to medtronic devices.All of them were procedural or post procedural complications related with the procedure and/or additional procedures such as cardiac surgery in an extremely high risk population.
 
Manufacturer Narrative
Relevant history: the study population had a prior medical history of diabetes mellitus (%) 21 (20.8) 158 (23.4) 0.55, smoker (%) 44 (43.5) 281(41.7) 0.72, coronary artery disease (%) 20 (19.8) 189 (28) 0.082, chronic renal failure (%) 4 (4) 21 (3.1) 0.65, atrial fibrillation (%) 4 (4) 21 (3.1) 0.65, prior carotid revascularization (%) 3 (3) 38 (5.6) 0.26, prior neurological event (%) 29 (28.79) 233 (34.5) 0.24.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600n nathan lane
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600n nathan lane
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6383330
MDR Text Key69205344
Report Number2183870-2017-00107
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeAR
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 02/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
-
-